HealthGenmab’s Cancer Combination Meets Both Primary Endpoints in Phase 3 TrialBy Naomi CalderOct 29, 2026, 12:09 AM UTC
HealthGenmab Reports Tumor Responses With Experimental Colorectal Cancer CombinationBy Naomi CalderOct 25, 2026, 11:21 AM UTC